Interviews
News Flash
Applied DNA Sciences Q3 FY20 sales down to $432,000
07 Aug '20
1 min read
Pic: Applied DNA Sciences
Applied DNA Sciences, a leader in polymerase chain reaction (PCR)-based DNA manufacturing, posted 79 per cent revenue decline to $432 thousand in its third quarter (Q3) fiscal 2020 ended on June 30, 2020 compared to revenue of $2.1 million in same period last year. Company incurred a net loss during the quarter of $3.3 million (Q3 FY19: $1.5 million).
“We continued during the quarter to position the company to serve the unmet and evolving needs for Covid-19 testing solutions and vaccine development,” Dr James Hayward, president and CEO of Applied DNA Sciences, said in a press release.
Selling, general and administrate expenses for the quarter were $2.5 million. Loss from the operation were $3.1 million ($1.4 million).
“Looking ahead, we are focused on advancing our Covid-19 diagnostic kit and TaaS market strategy and progressing the development of the linear DNA forms of our vaccine candidates,” Dr Hayward said.
Fibre2Fashion News Desk (JL)
Popular News
Leave your Comments
Editor’s Pick
Pratik Gadia
The Yarn Bazaar - Filosha Infotech Private Limited
Christian Guinet
French Textile Equipment Manufacturers’ Association (UCMTF)
Esteemed Clients
-Ltd..jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Thermore (Far East) Ltd.")
.jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Telangana State Industrial Infrastructure Corporation Limited (TSllC Ltd)")
.jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Taiwan Textile Federation (TTF)")
